Anesthesia Monitoring Devices Market Continues to Grow Owing to the Rising Demand for Surgical Procedures

 


Anesthesia is used to induce unconsciousness during a surgery. Anesthesia monitoring devices are used during a surgical process to check a patient's response toward anesthesia, as well as to track vital signs such as patient temperature, blood pressure, and heart rate under sedation in the operation theater. Moreover, these devices help reduce the risk involved in anesthesia. The need for these devices depends on the type of surgery and it varies in every case. Anesthesia monitoring devices help monitor the dose of anesthesia and reduces the risks involved in anesthesia and surgery.

Market Dynamics:

Increasing number of surgical procedures due to increasing incidence or prevalence of chronic diseases, such as cardiovascular diseases and cancer, is expected to propel the growth of the anesthesia monitoring devices market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking an estimated 17.9 million lives each year.

Moreover, increasing incidence of spinal disorders and the growing geriatric population is expected to augment the growth of the anesthesia monitoring devices market. According to the National Spinal Cord Injury Statistical Center, each year, around 17,700 new cases of spinal cord injury are diagnosed in the United States. In 2018, around 54 people in the U.S. (per one million) suffered from spinal cord injury.

Furthermore, the introduction of various new monitoring techniques, such as goal-directed fluid therapy, monitoring the depth of anesthesia, advanced neurological monitoring, and technological advancements are expected to drive the market growth. However, increase in product recalls and high cost of anesthesia monitoring devices is expected to restrain the anesthesia monitoring devices market growth.

Competitive Analysis:

Key players operating in the anesthesia monitoring devices market are Masimo, Heyer Medical AG, Criticare Systems, Inc., Schiller AG, Drägerwerk AG & Co. KGAA, Philips Healthcare, GE Healthcare, Covidien PLC (a subsidiary of Medtronic Plc.), Infinium Medical, Fukuda Denshi, Nihon Kohden Corporation, and Mindray Medical International Limited.

In March 2021, Masimo announced the CE marking of the Rad-G with Temperature, a rugged handheld device that provides clinically proven SET pulse oximetry, respiration rate from the pleth (RRp), and other important parameters alongside clinical-grade, non-contact infrared thermometry. 

In February 2021, Masimo announced the U.S. introduction of softFlow, innovative pulmonary care therapy which provides nasal high-flow warmed and humidified respiratory gases to spontaneously breathing patients.

In February 2021, Milestone Scientific Inc. announced that it has begun selling its CompuFlo Epidural Instrument and related disposables to the University Hospital of Wurzburg, one of the leading national hospitals in Germany.


Comments

Post a Comment

Popular posts from this blog

Increasing Consumption and Production of Fertilizers to Upsurge the Growth of the Agrochemicals Market

Image
  Agrochemical products are those chemicals that are used to increase the production of an agricultural environment. Agrochemical chemicals typically include pesticides, fertilizers, lime precursors, acidizing and alkalizing agents (all of which are designed to alter the normal pH level of the soil), lime stabilizers, and other nutrients that are required for plant growth. These chemicals are widely used by farmers and are crucial to the functioning of modern agriculture. The use of these chemicals presents a number of concerns both from the perspective of the environment and the human body. The increasing need for improving crop production due to the growing concern of food security and lack of arable land is fueling the growth of agrochemicals market . Growing advancement in technology is raising adoption of advanced and sustainable farming practices which is again propelling the growth of the market. The increasing population coupled with the growing usage of fertilizers aroun...
Read more

High Prevalence of Cancer and R&D in Anti-Cd39 Antibodies to Augment Growth of Anti-body Coupled T Receptor Therapy Market

Image
  Antibody-Coupled T cell Receptor (ACTR) is an autologous engineered T cell therapy that combines the Fc receptor, CD16, with endogenous T cell signaling and costimulatory domains. It is combined with tumor-targeting antibodies to exert potent anti-tumor immune responses and eliminate cancerous cells. ACRT has demonstrated potential in the treatment of multiple myeloma and HER2+ advanced cancers. Market Dynamics R&D in anti-CD39 antibodies is expected to propel growth of the Anti-body Coupled T Receptor Therapy Market . For instance, in December 2020, Arcus Biosciences, Inc. expanded its existing partnership with WuXi Biologics, a developer of biologics technology platforms, for R&D in anti-CD39 antibodies using WuXi Bio’s proprietary technology. Moreover, high prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 ...
Read more

Increasing Prevalence of Muscular Dystrophy to Augment the Muscular Dystrophy Treatment Market Growth

Image
  Muscular dystrophy is a common disease that causes muscles to become weaker and unable to continue to develop properly. Because it often affects young children as well as adults, it can be difficult to detect. However, once symptoms are noticed, steps must be taken to prevent the disease. There are many treatment options available for muscular dystrophy. The severity of the disease will determine what type of treatment is best for your situation. Muscular dystrophy treatment involves breathing aids, therapy, surgery, or medication, which may help maintain function, but life span is often shortened. Market Dynamics: Increasing prevalence or incidence of muscular dystrophy, especially in the North America, is expected to propel the growth of the muscular dystrophy treatment market . For instance, one in 3,500 male babies born worldwide are affected with Duchenne muscular dystrophy (DMD), according to the National Organization for Rare Disorders. Moreover, in 2019, around 349 ne...
Read more